• PDF: Delivered by email usually within 4 to 8 UK business hours.

Tanzania Pharmaceuticals and Healthcare Report Q2 2013

  • Publication Date:March 2013
  • Publisher:Business Monitor
  • Product Type: Report
  • Pages:41
  • ISBN:787410

Tanzania Pharmaceuticals and Healthcare Report Q2 2013

Includes 3 FREE quarterly updates

BMI View: The discovery and subsequent suspension of counterfeit antiretroviral drugs (ARVs) produced by the
country's first local manufacturer of ARVs highlights the ongoing lack of regulations and drug control mechanisms in
place in Tanzania The country is a market heavily reliant on imports, which bear the greatest risk of counterfeit
medication Combined with the discovery of a production facility producing fake drugs, this has led BMI to believe the
road to the availability of quality medicines to address the high burden of HIV and other diseases will be a long one
Headline Expenditure Projections
• Pharmaceuticals: TZS671 57bn (US$420mn) in 2012 to an anticipated TZS740 18bn (US$450mn) in 2013;
+10 2% growth in local currency terms and +7 4% in US dollar terms
• Healthcare: TZS2 74trn (US$1 72bn) in 2012 to TZS3 13trn (US$1 92bn) in 2013; 14 0% growth in local
currency terms and 11 2% in US dollar terms
BMI Industry View 5
SWOT Analysis 7
Tanzania Political SWOT 7
Tanzania Economic SWOT 7
Tanzania Business Environment SWOT 8
Pharmaceuticals Risk/Reward Ratings 9
Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q213 9
Rewards 10
Risks 11
Tanzania - Market Summary 12
Regulatory Regime 13
Intellectual Property Issues 13
Medicine Procurement 14
Industry Trends And Developments 18
Epidemiology 18
Industry Forecast Scenario 20
Pharmaceuticals Market Forecast 20
Table: Tanzania Pharmaceutical Sales, Historical Data and Forecasts 21
Healthcare Market Forecast 22
Table: Tanzania Healthcare Expenditure Trends, Historical Data and Forecasts 23
Table: Tanzania Government Healthcare Expenditure Trends, Historical Data and Forecasts 24
Table: Tanzania Private Healthcare Expenditure Trends, Historical Data and Forecasts 24
Macroeconomic Outlook 25
Table: Tanzania - Economic Activity 28
Competitive Landscape 29
Local Production 29
Opportunities In Government Financed And Donor Funded Healthcare Sector 29
Demographic Outlook 31
Table: Tanzania's Population By Age Group, 1990-2020 ('000) 32
Table: Tanzania's Population By Age Group, 1990-2020 (% of total) 33
Table: Tanzania's Key Population Ratios, 1990-2020 34
Table: Tanzania's Rural And Urban Population, 1990-2020 34
Glossary 35
BMI Methodology 37
How We Generate Our Pharmaceuticals Industry Forecasts 37
Pharmaceuticals Risk/Reward Ratings Methodology 38
Ratings Overview 38
Table: Pharmaceuticals Business Environment Indicators 39
Weighting 40
Table: Weighting Of Components 40
Sources 40
+44 20 8816 8548

Ask a question about Tanzania Pharmaceuticals and Healthcare Report Q2 2013

Enter the characters you see in the picture below
Captcha